PFM Health Sciences’s Werewolf Therapeutics HOWL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $437K | Sell |
401,110
-2,105,410
| -84% | -$2.29M | 0.04% | 56 |
|
|
2025
Q1 | $2.44M | Sell |
2,506,520
-398,945
| -14% | -$388K | 0.18% | 50 |
|
|
2024
Q4 | $4.3M | Sell |
2,905,465
-493,282
| -15% | -$730K | 0.27% | 49 |
|
|
2024
Q3 | $7.21M | Buy |
3,398,747
+157,673
| +5% | +$334K | 0.41% | 44 |
|
|
2024
Q2 | $7.91M | Buy |
3,241,074
+234,340
| +8% | +$572K | 0.39% | 47 |
|
|
2024
Q1 | $19.5M | Sell |
3,006,734
-461,443
| -13% | -$2.99M | 0.92% | 37 |
|
|
2023
Q4 | $13.4M | Buy |
3,468,177
+909,895
| +36% | +$3.51M | 0.8% | 42 |
|
|
2023
Q3 | $5.47M | Buy |
2,558,282
+254,391
| +11% | +$544K | 0.26% | 61 |
|
|
2023
Q2 | $7.03M | Buy |
2,303,891
+86,671
| +4% | +$264K | 0.27% | 62 |
|
|
2023
Q1 | $5.76M | Buy |
2,217,220
+923,927
| +71% | +$2.4M | 0.25% | 61 |
|
|
2022
Q4 | $2.65M | Sell |
1,293,293
-1,522,361
| -54% | -$3.12M | 0.09% | 67 |
|
|
2022
Q3 | $12.7M | Buy |
2,815,654
+1,084,931
| +63% | +$4.89M | 0.46% | 55 |
|
|
2022
Q2 | $7.08M | Buy |
1,730,723
+1,145,396
| +196% | +$4.68M | 0.27% | 65 |
|
|
2022
Q1 | $2.58M | Buy |
585,327
+185,327
| +46% | +$815K | 0.1% | 67 |
|
|
2021
Q4 | $4.76M | Hold |
400,000
| – | – | 0.16% | 62 |
|
|
2021
Q3 | $6.86M | Hold |
400,000
| – | – | 0.2% | 61 |
|
|
2021
Q2 | $6.98M | Buy |
+400,000
| New | +$6.98M | 0.22% | 66 |
|